Urocortin is a newly identified member of the corticotropin-releasing facto
r (CRF) neuropeptide family, and is known to be involved in the modulation
of the inflammatory process. We examined the expression of urocortin, CRF a
nd their receptors (CRF receptor; CRF-R) in the synovial tissue of patients
with rheumatoid arthritis (RA) in order to study the possible biological r
oles of urocortin. Synovial tissues/fluids were obtained from 38 patients w
ith RA, nine patients with osteoarthritis and four with trauma. We studied
the concentration of urocortin in the synovial fluid using RIA, and the exp
ression of urocortin in synovial tissue using immunohistochemistry, mRNA in
situ hybridization and reverse transcriptase-PCR (RT-PCR). In addition, we
examined the immunolocalization of CRF and the expression of CRF-R I, -R2-
alpha and -R2-beta mRNAs utilizing RT-PCR in these synovial tissues. Urocor
tin concentrations in synovial fluid were higher in RA patients (79.8 +/- 1
54 pg/ml) than in control patients (12.3 +/- 4.8 pg/ml; P less than or equa
l to 0.05). Urocortin immunoreactivity and mRNA signals were both detected
in synovial cells, lymphocytes, fibroblasts and macrophages. The number of
urocortin-positive cells in the synovium was significantly higher in RA (73
.1 +/- 32.1 cells per high-power field) than in control (18.4 +/- 10.4 cell
s per high-power field) patients. In addition, both urocortin immunoreactiv
ity and mRNA signals in the synovium reached maximum levels in the active s
tage of RA inflammation. Moreover, the number of immunoreactive urocortin-p
ositive cells was significantly correlated with the urocortin concentration
in synovial fluid (r = 0.705; P < 0.001) and with histologically defined l
ocal inflammatory activity (r = 0.641; P(0.001). The distribution and numbe
r of immunoreactive CRF-positive cells in synovial tissue were similar to t
hose of urocortin-positive cells (r = 0.701; P < 0.001). Urocortin, CRF-RI
and CRF-R2-alpha mRNAs detected by RT-PCR were expressed in in the synovium
of 10/10, 10/10 and 2/10 RA patients respectively, but CRF-R2-beta was not
expressed. Urocortin was actively synthesized in the synovium of RA patien
ts. The present study suggests that urocortin may play an important role as
an autocrine and/or paracrine regulator of synovial inflammation in RA.